The biofilm formed in local lesions by Pseudomonas aeruginosa is mainly composedofalginate and considered to be a barrier against host defense mechanismsand chemotherapeutic agents, causing serious and chronic infections1~3).
Alginate is a polymer consisting of /?-D-mannuronate and its epimer a-L-guluronate, and P. aeruginosa jS-D-mannuronate has been characterized to be O-acetylated at a higher rate in comparison with others4'5).
Guanosine diphosphomannose dehydrogenase (GMD) is characterized as the key enzyme in alginate formation in P. aeruginosa6~8\ Therefore, substances that specifically inhibit GMD activity are expected to be effective therapeutic agents against biofilm-forming P. aeruginosa. We reported that morphological alteration of mucoid to non-mucoid in P. aeruginosa and inhibition on GMDactivity might be an useful method to screen alginate biosynthetic inhibitors from microbial metabolites9). In this paper we describe mucoid to non-mucoid alteration, inhibition of alginate production, and GMDinhibition by clinically used antibacterial agents and their relationship.
The P. aeruginosa PAM38which constitutively formed mucoidcolonies was used for the determination of the minimumconcentration inducing non-mucoidalteration (MCINA)and for measurement of alginate production. Minimum inhibitory concentration (MIC) and MCINA were examined by an agar dilution method. Alginate production was estimated by HPLCaccording to the pp.65 -61 method ofToyoda et al.m and inhibitory rate ofalginate formation was expressed by the percent ratio of HPLC peak area. The enzymeGMD was purified from a culture of P. aeruginosa strain PAM17 which produced the enzyme in large amounts by the method of Roychoudhury8) with some modifications.
The following antibacterial agents were used: erythromycin A (EM-A), clarithromycin (CAM), azithromycin (AZM), oleandomycin (OL), josamycin (JM), gentamicin (GM), clindamycin (CLDM) and chloramphenicol (CP). Penicillic acid (PCA) was found in the screening system using morphological alteration of mucoid to non-mucoid in P. aeruginosa9).
In order to know whether the decrease of alginate production resulted from growth inhibition by the antibacterial agents used, the amounts of alginate produced under various concentrations (1/4, 1/16, 1/64 and 1/256 MIC) of the agents were estimated by HPLC analysis. Viable cell counts in all the cultures were not affected under the condition of 1/4 MICor less of the agents, indicating that a decrease in alginate formation is not concerned by bacterial viability. Table 1 summarizes MIC values of antibacterial agents against P. aeruginosa, their inhibitory effects on alginate production, MCINAand GMDactivity.
As shown in Table 1 , low concentration of AZM(0.78jug/m\), CP (0.78 /ig/ml) and PCA (6.25 jUg/ml), which corresponds to 1/256 MIC showed strong inhibition of alginate formation, 75, 94 and 85%, respectively. EM-A, CAM, OL and CLDMshowed the inhibition dose-dependently. On the other hand, the inhibitory activity by JM and GMwas lower level.
As it was predicted that a decrease in alginate formation might result from inhibition of GMD activity, we examined the relation between MCINAactivity and inhibitory effect on GMDby antibacterial agents. Table   1 summarizes MCINA for PAM38 strain and 50% inhibitory concentrations (IC50) for GMDactivity by agents. As expected, inducibility of non-mucoid alteration by each agent except for JM related to the inhibition of alginate formation. The non-mucoid alteration of GMcould not be determined because of its antibacterial activity against P. aeruginosa. AZMand CP showed a low MCINA(0.78 jUg/ml). Inhibitory activities on mucoid formation of EM-Aand CAM were relatively low with MCINA6.25/ig/ml, but that of OL, JM and CLDMwere weak (MCINA100 /jg/ml). On the contrary, the IC50 for GMDactivity were 1.1him for EM-A and 0.6mM for AZM in which their inhibitory activities a Inhibitory effect on alginate production of OL, CLDMand PCAwas examined as MIC; 1600^g/ml.
were not strong. The other agents, OL, JM, CAM,CP, CLDMand GMhad almost no GMDinhibitory activity. The inhibitory concentrations above 1.0niM of CAM and JM could not be determined because of their low solubility in the solvent. Nodetectable inhibitory activity of CP and PCAon GMDwere observed, although the agent strongly inhibited alginate production. The inhibition on alginate production and non-mucoid alteration did not always correlate to the inhibitory activity on GMD, indicating that the inhibition on alginate production of CP and PCA1 1} might result from such mode of actions as inhibition of protein synthesis and cytotoxicity, respectively. Kobayashi et al.12) have reported that the inhibitory effect of EM-Aand AZM on GMD is related to a decrease on alginate production. Our results suggest that none of EM, CAM, AZMand CPwould be a specific inhibitor ofGMD, although these agents resulted in the suppression of alginate production. Tateda et al.13 ) have reported that sub-MICs of AZM affect viability and protein synthesis in several strains of P. aeruginosa, due to the excellent permeability through the bacterial membrane. Although the possibility remains to be examined, it can be predicted that the high non-mucoid alteration but a weak inhibition of EM-A and AZMon GMDactivity, in comparison with OL and JM seems to be due to the difference of permeability through the bacterial membrane, not a direct inhibition on GMD and may be attributable to the suppression of alginate-biosynthesis-related enzyme systems resulting from inhibition of protein synthesis in P. aeruginosa. 
